JP2009535352A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535352A5
JP2009535352A5 JP2009507893A JP2009507893A JP2009535352A5 JP 2009535352 A5 JP2009535352 A5 JP 2009535352A5 JP 2009507893 A JP2009507893 A JP 2009507893A JP 2009507893 A JP2009507893 A JP 2009507893A JP 2009535352 A5 JP2009535352 A5 JP 2009535352A5
Authority
JP
Japan
Prior art keywords
hiv
compound
pharmaceutically acceptable
group
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009507893A
Other languages
English (en)
Other versions
JP2009535352A (ja
JP5214590B2 (ja
Filing date
Publication date
Priority claimed from US11/733,283 external-priority patent/US7807671B2/en
Application filed filed Critical
Publication of JP2009535352A publication Critical patent/JP2009535352A/ja
Publication of JP2009535352A5 publication Critical patent/JP2009535352A5/ja
Application granted granted Critical
Publication of JP5214590B2 publication Critical patent/JP5214590B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (6)

  1. Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
    Figure 2009535352
     ：からなる群から選択される化合物。
  2. 請求項１に記載の化合物、またはその医薬的に許容される塩の抗ウイルス有効量、および一つ以上の医薬的に許容される担体、賦形剤または希釈剤を含む、医薬組成物。
  3. 抗ＨＩＶ活性を有する第２の化合物をさらに含む、請求項２に記載の組成物。
  4. （ａ）抗ＡＩＤＳウイルス薬；
    （ｂ）抗感染症薬；
    （ｃ）免疫調節剤； および
    （ｄ）ＨＩＶ侵入阻害剤
    ：からなる群から選択されるＡＩＤＳ治療薬の抗ウイルス有効量をさらに含む、ＨＩＶによる感染を治療するための請求項２に記載の医薬組成物。
  5. ＨＩＶを治療するための医薬の製造における、請求項１に記載の化合物、またはその医薬的に許容される塩の使用。
  6. ＨＩＶを治療するための医薬の製造における、請求項１に記載の化合物、またはその医薬的に許容される塩、ならびに、抗ＡＩＤＳウイルス薬； 抗感染症薬； 免疫調節剤； およびＨＩＶ侵入阻害剤からなる群から選択されるＡＩＤＳ治療薬の使用。
JP2009507893A 2006-04-25 2007-04-16 抗ウイルス薬としてのジケト−ピペラジンおよびピペリジン誘導体 Active JP5214590B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US79470306P 2006-04-25 2006-04-25
US79470006P 2006-04-25 2006-04-25
US60/794,703 2006-04-25
US60/794,700 2006-04-25
US11/733,283 US7807671B2 (en) 2006-04-25 2007-04-10 Diketo-piperazine and piperidine derivatives as antiviral agents
US11/733,283 2007-04-10
PCT/US2007/066700 WO2007127635A2 (en) 2006-04-25 2007-04-16 Diketo-piperazine and piperidine derivatives as antiviral agents

Publications (3)

Publication Number Publication Date
JP2009535352A JP2009535352A (ja) 2009-10-01
JP2009535352A5 true JP2009535352A5 (ja) 2010-06-03
JP5214590B2 JP5214590B2 (ja) 2013-06-19

Family

ID=38335673

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009507893A Active JP5214590B2 (ja) 2006-04-25 2007-04-16 抗ウイルス薬としてのジケト−ピペラジンおよびピペリジン誘導体

Country Status (17)

Country Link
US (2) US7807671B2 (ja)
EP (1) EP2010525B1 (ja)
JP (1) JP5214590B2 (ja)
KR (1) KR101450349B1 (ja)
AR (1) AR060658A1 (ja)
AU (1) AU2007242989B2 (ja)
BR (1) BRPI0710919A2 (ja)
CA (1) CA2650382C (ja)
EA (1) EA014957B1 (ja)
ES (1) ES2432758T3 (ja)
IL (1) IL194540A (ja)
MX (1) MX2008013265A (ja)
NO (1) NO341412B1 (ja)
NZ (1) NZ571995A (ja)
PE (1) PE20080318A1 (ja)
TW (1) TWI394754B (ja)
WO (1) WO2007127635A2 (ja)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20050075364A1 (en) * 2003-07-01 2005-04-07 Kap-Sun Yeung Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100209A1 (en) * 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
US7504399B2 (en) 2006-06-08 2009-03-17 Bristol-Meyers Squibb Company Piperazine enamines as antiviral agents
US8653262B2 (en) * 2007-05-31 2014-02-18 Boehringer Ingelheim International Gmbh CCR2 receptor antagonists and uses thereof
BRPI0814758A2 (pt) * 2007-08-03 2015-03-03 Hoffmann La Roche Piridinacarboxamida e derivados de benzamida como ligantes taar1
JP5433691B2 (ja) * 2008-06-25 2014-03-05 ブリストル−マイヤーズ スクイブ カンパニー Ｈｉｖ結合阻害剤としてのジケトピペリジン誘導体
US7960406B2 (en) 2008-06-25 2011-06-14 Bristol-Myers Squibb Company Diketo substituted pyrrolo[2,3-c] pyridines
EP2311822A4 (en) * 2008-08-01 2011-08-31 Nippon Chemiphar Co GPR119 AGONIST
CA2735008C (en) * 2008-09-04 2016-11-29 Bristol-Myers Squibb Company Extended release formulation for optimized delivery of an hiv attachment inhibitor
MA33085B1 (fr) 2008-12-19 2012-03-01 Boehringer Ingelheim Int Pyrimidine-4 carboxamides cycliques en tant qu'antagonistes du recepteur ccr2 pour le traitement d'inflammations, de l'asthme et des broncho-pneumopathies chroniques obstructives
JP5807971B2 (ja) 2009-04-27 2015-11-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｘｃｒ３受容体アンタゴニスト
JP5632014B2 (ja) 2009-12-17 2014-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ｃｃｒ２受容体アンタゴニスト及びこれらの使用
WO2011084985A1 (en) 2010-01-07 2011-07-14 Boehringer Ingelheim International Gmbh Cxcr3 receptor antagonists
TW201200518A (en) * 2010-03-10 2012-01-01 Kalypsys Inc Heterocyclic inhibitors of histamine receptors for the treatment of disease
US8946218B2 (en) 2010-05-12 2015-02-03 Boehringer Ingelheim International Gmbh CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP2013526507A (ja) 2010-05-12 2013-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用
EP2571870B1 (en) 2010-05-17 2015-01-21 Boehringer Ingelheim International GmbH Ccr2 antagonists and uses thereof
US9018212B2 (en) 2010-05-25 2015-04-28 Boehringer Ingelheim International Gmbh Pyridazine carboxamides as CCR2 receptor antagonists
US8962656B2 (en) 2010-06-01 2015-02-24 Boehringer Ingelheim International Gmbh CCR2 antagonists
JP5613461B2 (ja) * 2010-06-02 2014-10-22 日本農薬株式会社 ピリミジン誘導体及び該誘導体を含有する農園芸用殺虫剤並びにその使用方法
WO2011159794A1 (en) * 2010-06-17 2011-12-22 Bristol-Myers Squibb Company Deuterated hiv attachment inhibitors
US8450361B2 (en) 2010-08-06 2013-05-28 Bristol-Myers Squibb Company Substituted indole and azaindole oxoacetyl piperazinamide derivatives
ES2585396T3 (es) 2010-12-02 2016-10-05 VIIV Healthcare UK (No.5) Limited Alquilamidas como inhibidores de la unión del VIH
EP2696937B1 (en) * 2011-04-12 2017-05-17 VIIV Healthcare UK (No.5) Limited Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors
WO2013010839A1 (en) 2011-07-15 2013-01-24 Boehringer Ingelheim International Gmbh Novel and selective ccr2 antagonists
WO2013039785A2 (en) 2011-09-12 2013-03-21 Kalypsys, Inc. Heterocyclic inhibitors of histamine receptors for the treatment of disease
ES2616492T3 (es) * 2012-08-09 2017-06-13 VIIV Healthcare UK (No.5) Limited Derivados de piperidina amida como inhibidores de la fijación del VIH
MX2015002887A (es) 2012-09-06 2015-07-06 Plexxikon Inc Compuestos y metodos para la modulacion de cinasas, e indicaciones para ello.
UA115156C2 (uk) 2012-12-11 2017-09-25 Такеда Фармасьютікал Компані Лімітед Гетероциклічна сполука
ES2753386T3 (es) 2013-03-13 2020-04-08 Forma Therapeutics Inc Derivados de 2-hidroxi-1-{4-[(4-fenil)fenil]carbonil}piperazin-1-il}etano-1-ona y compuestos relacionados como inhibidores de sintasa de ácido graso (FASN) para el tratamiento del cáncer
CN105283455B (zh) * 2013-03-27 2017-06-16 百时美施贵宝公司 作为hiv吸附抑制剂的2‑酮基酰胺衍生物
EP2978762A1 (en) * 2013-03-27 2016-02-03 Bristol-Myers Squibb Company Piperazine and homopiperazine derivatives as hiv attachment inhibitors
US10259807B2 (en) 2013-07-22 2019-04-16 Idorsia Pharmaceuticals Ltd. 1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives
WO2015063709A1 (en) * 2013-10-31 2015-05-07 Ranbaxy Laboratories Limited Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine
AR103399A1 (es) 2015-01-15 2017-05-10 Actelion Pharmaceuticals Ltd Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
EA032927B1 (ru) 2015-01-15 2019-08-30 Идорсия Фармасьютиклз Лтд Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
EP3317270B1 (en) 2015-07-02 2020-05-13 Centrexion Therapeutics Corporation (4-((3r,4r)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2r,6s)-6-(p-tolyl)tetrahydro-2h-pyran-2-yl)methylamino)pyrimidin-4yl)methanone citrate
KR102014335B1 (ko) * 2017-12-01 2019-08-26 한국과학기술연구원 5-ht7 수용체의 조절제로 작용하는 아릴피라졸릴피페라진 또는 아릴피라졸릴다이아제페인의 유도체 및 이를 포함하는 중추신경계 질환 치료 또는 예방용 약학 조성물
CN113382633A (zh) 2018-10-29 2021-09-10 福马治疗股份有限公司 (4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式
TWI784207B (zh) 2018-11-02 2022-11-21 美商默沙東有限責任公司 作為nav1.8 抑制劑之2-胺基-n-雜芳基-菸鹼醯胺
CN111004213B (zh) * 2019-12-26 2021-07-20 北京欣奕华科技有限公司 一种有机电致发光化合物及其应用
TW202321229A (zh) * 2021-08-18 2023-06-01 美商富曼西公司 殺真菌的取代的雜環化合物

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (ja) 1959-09-25 1900-01-01
GB8615562D0 (en) 1986-06-25 1986-07-30 Maggioni Farma Aminoalcohols
MX19185A (es) 1989-01-20 1993-12-01 Pfizer Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.
US5023265A (en) 1990-06-01 1991-06-11 Schering Corporation Substituted 1-H-pyrrolopyridine-3-carboxamides
IL99843A0 (en) 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors
US5811432A (en) 1990-11-09 1998-09-22 Pfizer Inc Azaoxindole derivatives
US5192770A (en) 1990-12-07 1993-03-09 Syntex (U.S.A.) Inc. Serotonergic alpha-oxoacetamides
AU653855B2 (en) 1991-07-03 1994-10-13 Pharmacia & Upjohn Company Indolyl carbonyl pyridinyl-poperazine/piperidine derivatives
WO1993005020A1 (en) 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase
US5124327A (en) 1991-09-06 1992-06-23 Merck & Co., Inc. HIV reverse transcriptase
US5413999A (en) 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
IT1265057B1 (it) 1993-08-05 1996-10-28 Dompe Spa Tropil 7-azaindolil-3-carbossiamidi
US5424329A (en) 1993-08-18 1995-06-13 Warner-Lambert Company Indole-2-carboxamides as inhibitors of cell adhesion
GB9420521D0 (en) 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
TW429256B (en) 1995-12-27 2001-04-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
WO1998008842A1 (en) 1996-08-29 1998-03-05 Takeda Chemical Industries, Ltd. Cyclic ether compounds as sodium channel modulators
DE19636150A1 (de) 1996-09-06 1998-03-12 Asta Medica Ag N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung
WO1998028292A1 (en) 1996-12-23 1998-07-02 Smithkline Beecham Corporation Novel piperidine containing compounds
WO1999024065A1 (en) 1997-11-10 1999-05-20 The Trustees Of Columbia University In The City Of New York COMPOUNDS INHIBITING CD4-gp120 INTERACTION AND USES THEREOF
RU2217421C2 (ru) 1998-03-26 2003-11-27 Шионоги & Ко., Лтд. Производные индола, обладающие антивирусной активностью
DE19814838C2 (de) 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
CA2335711A1 (en) 1998-06-19 1999-12-29 Ivan Mikkelsen 4,5,6 and 7-indole and indoline derivatives, their preparation and use
CA2335448A1 (en) 1998-06-30 2000-01-06 Michael John Martinelli Bicyclic spla2 inhibitors
WO2000012074A2 (en) 1998-08-28 2000-03-09 Scios Inc. Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
GB9905010D0 (en) 1999-03-04 1999-04-28 Merck Sharp & Dohme Therapeutic agents
AU772295B2 (en) 1999-05-21 2004-04-22 Scios Inc. Indole-type derivatives as inhibitors of p38 kinase
US6469006B1 (en) 1999-06-15 2002-10-22 Bristol-Myers Squibb Company Antiviral indoleoxoacetyl piperazine derivatives
TWI269654B (en) 1999-09-28 2007-01-01 Baxter Healthcare Sa N-substituted indole-3-glyoxylamide compounds having anti-tumor action
US20020061892A1 (en) 2000-02-22 2002-05-23 Tao Wang Antiviral azaindole derivatives
US6476034B2 (en) 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
ATE304853T1 (de) 2000-07-10 2005-10-15 Bristol Myers Squibb Co Zusammensetzung und antivirale wirkung von substituierten indol-oxo-aceto-piperidin- derivaten
US6573262B2 (en) 2000-07-10 2003-06-03 Bristol-Myers Sqibb Company Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
DE10037310A1 (de) 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
KR20030079979A (ko) 2001-02-02 2003-10-10 브리스톨-마이어스스퀴브컴파니 치환된 아자인돌옥소아세틱 피페라진 유도체의 조성물 및항바이러스 활성
US20030207910A1 (en) 2001-02-02 2003-11-06 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20040110785A1 (en) 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US6825201B2 (en) 2001-04-25 2004-11-30 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic amidopiperazine derivatives
US6667378B2 (en) 2001-06-22 2003-12-23 L'oreal, S.A. Reshapable hair styling composition comprising heterogeneous (meth)acrylic copolymer particles
PL369019A1 (en) 2001-11-09 2005-04-18 Scios Inc. Method to treat cystic fibrosis
US20030236277A1 (en) 2002-02-14 2003-12-25 Kadow John F. Indole, azaindole and related heterocyclic pyrrolidine derivatives
WO2003082881A2 (en) 2002-03-28 2003-10-09 Procyon Biopharma Inc. Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors
US7037913B2 (en) 2002-05-01 2006-05-02 Bristol-Myers Squibb Company Bicyclo 4.4.0 antiviral derivatives
US7348337B2 (en) 2002-05-28 2008-03-25 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
US20040063744A1 (en) 2002-05-28 2004-04-01 Tao Wang Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
WO2003103607A2 (en) 2002-06-11 2003-12-18 Bristol-Myers Squibb Company Viral envelope mediated fusion assay
US6900206B2 (en) 2002-06-20 2005-05-31 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
US20040063746A1 (en) 2002-07-25 2004-04-01 Alicia Regueiro-Ren Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives
US20050075364A1 (en) 2003-07-01 2005-04-07 Kap-Sun Yeung Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
EA200600225A1 (ru) 2003-08-14 2006-08-25 Пфайзер Инк. Производные пиперазина для лечения вич инфекций
US20050124623A1 (en) 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
US7745625B2 (en) 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
US20050215543A1 (en) 2004-03-24 2005-09-29 Pin-Fang Lin Methods of treating HIV infection
US7776863B2 (en) 2004-03-24 2010-08-17 Bristol-Myers Squibb Company Methods of treating HIV infection
US20050215544A1 (en) 2004-03-24 2005-09-29 Pin-Fang Lin Methods of treating HIV infection
US7449476B2 (en) 2004-05-26 2008-11-11 Bristol-Myers Squibb Company Tetrahydrocarboline antiviral agents
US7087610B2 (en) 2004-06-03 2006-08-08 Bristol-Myers Squibb Company Benzothiazole antiviral agents
WO2005121094A1 (en) 2004-06-09 2005-12-22 Pfizer Limited Piperazine and piperidine derivatives as anti-hiv-agents
US20060100432A1 (en) 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100209A1 (en) 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7183284B2 (en) 2004-12-29 2007-02-27 Bristol-Myers Squibb Company Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
US7396830B2 (en) 2005-10-04 2008-07-08 Bristol-Myers Squibb Company Piperazine amidines as antiviral agents
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
US7501419B2 (en) 2006-04-25 2009-03-10 Bristol-Myers Squibb Company 4-Squarylpiperazine derivatives as antiviral agents
US7504399B2 (en) * 2006-06-08 2009-03-17 Bristol-Meyers Squibb Company Piperazine enamines as antiviral agents
US7572810B2 (en) * 2006-06-08 2009-08-11 Bristol-Myers Squibb Company Alkene piperidine derivatives as antiviral agents

Similar Documents

Publication Publication Date Title
JP2009535352A5 (ja)
JP2011528713A5 (ja)
JP2013518107A5 (ja)
JP2017057230A5 (ja)
MX2012007410A (es) Compuestos antivirales novedosos.
JP2015038149A5 (ja)
JP2017531038A5 (ja)
JP2009502743A5 (ja)
SI2932970T1 (en) Antiviral therapy
JP2013507439A5 (ja)
EA201171376A1 (ru) Производные тиено[2,3-b]пиридина в качестве ингибиторов репликации вируса
JP2020097577A5 (ja)
JP2012532874A5 (ja)
RU2013119607A (ru) Полициклические гетероциклические соединения и способы их применения для лечения вирусных заболеваний
JP2012255026A5 (ja)
JP2013508279A5 (ja)
JP2010503396A5 (ja)
TW200600492A (en) Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2012065963A3 (en) Antiviral condensed heterocyclic compounds
JP2010285436A5 (ja)
JP2010270130A5 (ja)
WO2005067900A3 (en) Azabenzofuran substituted thioureas as inhibitors of viral replication
JP2020512337A5 (ja)
WO2005095345A3 (en) Heteroaryl guanidines as inhibitors of viral replication
JP2010500284A5 (ja)